Posts tagged “Emory”
George Painter brings 30 years experience to Emory University. In other regional life science news, Wake Forest Innovations finds a partner for health mobile apps development and Cornerstone Therapeutics sues a rival for patent infringement.
Aiming to combine university lab resources with industry leadership, Emory announced it is launching Drug Innovation Ventures at Emory, or DRIVE, a not-for-profit company that is separate from the Emory but still owned by the university.
UNC-Chapel Hill, Duke and Wake Forest are teaming up with several other universities to offer online undergraduate courses for credit and that can be taken at a member university where a student isn't enrolled.
Hatteras Venture Partners is backing Georgia-based Clearside Biomedical which is developing a drug delivery platform for eye medications.
STATE OF VENTURE: Spectropath's imaging technology was developed at Emory University and the Georgia Institute of Technology, and spun into a company in 2010. Spectropath has already raised about $417,000 in its first round of funding.
Many more people afflicted with cancer also now receive outpatient care. Researchers at RTI International, Emory University and CDC report that costs increased to $48.1 billion in 2005 from inflation-adjusted total of $24.7 billion in 1987.
The drug giant will allow outside scientists to access its data and also broaden efforts to combat other maladies through its recently announced patent pool, CEO Andrew Witty says. Emory University's Institute for Drug Discovery will be a partner.
Five North Carolina companies are each gaining a research scientist – at no cost – as part of the new “Industrial Fellowships Program” funded by the North Carolina Biotechnology Center.